BIOMAT Database Logo BIOMAT Database Logo

Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugate. 2002

Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Department of Ophthalmology, Medical University of South Carolina, 280 Calhoun Street, Charleston, South Carolina 29425-2301, USA.

A novel conjugate of mitomycin C (MMC) and triamcinolone acetonide (TA) was synthesized using glutaric acid as a linker molecule. To determine the rate of hydrolysis, the conjugate was dissolved in aqueous solution and the rate of appearance of free MMC and TA was determined by high-performance liquid chromatography analysis. Antiproliferative activity of the MMC-TA conjugate and parent compounds was assessed using an NIH 3T3 fibroblast cell line. Cell growth was quantified using the MTT assay. Kinetic analysis of the hydrolysis rate demonstrated that the conjugate had a half-life of 23.6 h in aqueous solutions. The antiproliferative activities of the MMC-TA conjugate and MMC were both concentration dependent, with similar IC(50) values of 2.4 and 1.7 microM, respectively. However, individual responses at concentrations above 3 microM showed that the conjugate was less active than MMC alone. TA alone showed only limited inhibition of cell growth. Studies evaluating intravitreal injection of the conjugate demonstrate that this agent produced no measurable toxicity. Our data provide evidence that the MMC-TA conjugate could be used as a slow-release drug delivery system. This could in turn be used to modulate a posttreatment wound healing process or to treat various proliferative diseases.

UI MeSH Term Description Entries
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D005260 Female Females
D005977 Glutarates Derivatives of glutaric acid (the structural formula (COO-)2C3H6), including its salts and esters. Glutarate
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014222 Triamcinolone Acetonide An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. Azmacort,Cinonide,Kenacort A,Kenalog,Kenalog 40,Tricort-40,Acetonide, Triamcinolone,Tricort 40,Tricort40
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3

Related Publications

Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits.
January 2014, Molecular vision,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study.
January 2006, Retina (Philadelphia, Pa.),
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.
January 1984, Drug metabolism and disposition: the biological fate of chemicals,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.
January 2000, Ophthalmic surgery and lasers,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Design and synthesis of TPP+-Mitomycin C conjugate with reduced toxicity.
December 2022, Bioorganic & medicinal chemistry letters,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Toxicity of triamcinolone acetonide.
October 1981, American journal of ophthalmology,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Triamcinolone acetonide. Subacute toxicity studies in the rat.
August 1960, Oral surgery, oral medicine, and oral pathology,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.
February 2006, Investigative ophthalmology & visual science,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.
February 2007, Experimental eye research,
Tamer A Macky, and Carsten Oelkers, and Uwe Rix, and Martin L Heredia, and Eva Künzel, and Mark Wimberly, and Baerbel Rohrer, and Craig E Crosson, and Jürgen Rohr
Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin C.
January 1980, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!